In trading on Monday, shares of La Jolla Pharmaceutical Co. (NASDAQ:LJPC) touched a new 52-week high of $39.28/share. That's a 175.84% rise, or $25.04 per share from the 52-week low of $14.24 set back on 05/06/2016. That means at today's intraday high, any investor who purchased LJPC stock any time over the past 52 weeks has an unrealized gain, including company insiders.
Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, LJPC has seen 5 different instances of insiders buying over the trailing six month period.
This Article's Word Cloud:BargainsCheaperChiefDirectorFinancialGeorgeInsiderKevinLJPCLakhmirMedicalMondayMulroyOfficerOverPharmaceuticalPricePurchasedShareStartTangThatValueafternoonbelowbuyingchangingfromhandsomelyhavehighinsidersintradaymonthmonthsoverpastperiodpurchasedrisesharesharessummarizedtabletimetouchedtradingweekwherewith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.